{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:54:26Z","timestamp":1769835266539,"version":"3.49.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human cytomegalovirus (HCMV) is an ubiquitous herpesvirus that can cause serious morbidity and mortality in immunocompromised or immune-immature individuals. A vaccine that induces immunity to CMV in these target populations is therefore highly needed. Previous attempts to generate efficacious CMV vaccines primarily focused on the induction of humoral immunity by eliciting neutralizing antibodies. Current insights encourage that a protective immune response to HCMV might benefit from the induction of virus-specific T cells. Whether addition of antiviral T cell responses enhances the protection by antibody-eliciting vaccines is however unclear. Here, we assessed this query in mouse CMV (MCMV) infection models by developing synthetic vaccines with humoral immunity potential, and deliberately adding antiviral CD8<jats:sup>+<\/jats:sup> T cells. To induce antibodies against MCMV, we developed a DNA vaccine encoding either full-length, membrane bound glycoprotein B (gB) or a secreted variant lacking the transmembrane and intracellular domain (secreted (s)gB). Intradermal immunization with an increasing dose schedule of sgB and booster immunization provided robust viral-specific IgG responses and viral control. Combined vaccination of the sgB DNA vaccine with synthetic long peptides (SLP)-vaccines encoding MHC class I-restricted CMV epitopes, which elicit exclusively CD8<jats:sup>+<\/jats:sup> T cell responses, significantly enhanced antiviral immunity. Thus, the combination of antibody and CD8<jats:sup>+<\/jats:sup> T cell-eliciting vaccines provides a collaborative improvement of humoral and cellular immunity enabling enhanced protection against CMV.<\/jats:p>","DOI":"10.3389\/fimmu.2022.680559","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:08:52Z","timestamp":1643281732000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Dominant Antiviral CD8+ T Cell Responses Empower Prophylactic Antibody-Eliciting Vaccines Against Cytomegalovirus"],"prefix":"10.3389","volume":"13","author":[{"given":"Iris N.","family":"Pardieck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"van Duikeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique M. B.","family":"Veerkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena J.","family":"Brasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Redeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"van Bergen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanda","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferry","family":"Ossendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerben","family":"Zondag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Arens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.655","article-title":"Review of Cytomegalovirus Seroprevalence and Demographic Characteristics Associated With Infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of Human Cytomegalovirus: From Bench to Bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0000000000000666","article-title":"Updates on Antiviral Drugs for Cytomegalovirus Prevention and Treatment","volume":"24","author":"Kotton","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: Shape-Shifting the Immune System","volume":"200","author":"Picarda","year":"2018","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343946","article-title":"Viral Inoculum Dose Impacts Memory T-Cell Inflation","volume":"44","author":"Redeker","year":"2014","journal-title":"Eur J Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167097","article-title":"Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation","volume":"11","author":"Trgovcich","year":"2016","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01953","article-title":"The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose","volume":"8","author":"Redeker","year":"2017","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.5.1713","article-title":"Antibodies Are Not Essential for the Resolution of Primary Cytomegalovirus Infection But Limit Dissemination of Recurrent Virus","volume":"179","author":"Jonjic","year":"1994","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095414","article-title":"Protection From CMV Infection in Immunodeficient Hosts by Adoptive Transfer of Memory B Cells","volume":"110","author":"Klenovsek","year":"2007","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03177-15","article-title":"Viral Persistence Induces Antibody Inflation Without Altering Antibody Avidity","volume":"90","author":"Welten","year":"2016","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199203053261003","article-title":"The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043337","article-title":"Passive Immunization During Pregnancy for Congenital Cytomegalovirus Infection","volume":"353","author":"Nigro","year":"2005","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1115","article-title":"Antiviral Antibody Responses and Intrauterine Transmission After Primary Maternal Cytomegalovirus Infection","volume":"171","author":"Boppana","year":"1995","journal-title":"J Infect Dis"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710223171703","article-title":"Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant Recipients","volume":"317","author":"Snydman","year":"1987","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.3.1079-1085.1990","article-title":"Cell Surface Expression of Human Cytomegalovirus (HCMV) Gp55-116 (Gb): Use of HCMV-Recombinant Vaccinia Virus-Infected Cells in Analysis of the Human Neutralizing Antibody Response","volume":"64","author":"Britt","year":"1990","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.2.381","article-title":"Antibodies to Recombinant-Derived Glycoprotein B After Natural Human Cytomegalovirus Infection Correlate With Neutralizing Activity","volume":"165","author":"Marshall","year":"1992","journal-title":"J Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800224115","article-title":"Protection From Cytomegalovirus Viremia Following Glycoprotein B Vaccination Is Not Dependent on Neutralizing Antibodies","volume":"115","author":"Baraniak","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV Glycoprotein B Subunit Vaccine Efficacy Mediated by Nonneutralizing Antibody Effector Functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006601","article-title":"Protective Capacity of Neutralizing and Non-Neutralizing Antibodies Against Glycoprotein B of Cytomegalovirus","volume":"13","author":"Bootz","year":"2017","journal-title":"PloS Pathog"},{"key":"B20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.32607\/20758251-2019-11-4-22-32","article-title":"Non-Neutralizing Antibodies Directed at Conservative Influenza Antigens","volume":"11","author":"Sedova","year":"2019","journal-title":"Acta Naturae"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.188.6.1047","article-title":"Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication During Latent Infection","volume":"188","author":"Polic","year":"1998","journal-title":"J Exp Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.6.4283","article-title":"Massive Load of Functional Effector CD4+ and CD8+ T Cells Against Cytomegalovirus in Very Old Subjects","volume":"179","author":"Vescovini","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050882","article-title":"Broadly Targeted Human Cytomegalovirus-Specific CD4+ and CD8+ T Cells Dominate the Memory Compartments of Exposed Subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2022","article-title":"Memory Inflation: Continuous Accumulation of Antiviral CD8+ T Cells Over Time","volume":"170","author":"Karrer","year":"2003","journal-title":"J Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.it.2011.11.005","article-title":"Memory T Cell Inflation: Understanding Cause and Effect","volume":"33","author":"O\u2019Hara","year":"2012","journal-title":"Trends Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-019-00608-7","article-title":"The Hallmarks of CMV-Specific CD8 T-Cell Differentiation","volume":"208","author":"van den Berg","year":"2019","journal-title":"Med Microbiol Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00202","article-title":"The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People","volume":"10","author":"Lim","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.5.1373.1373","article-title":"Cytotoxic T-Lymphocyte Response to Cytomegalovirus After Human Allogeneic Bone Marrow Transplantation: Pattern of Recovery and Correlation With Cytomegalovirus Infection and Disease","volume":"78","author":"Reusser","year":"1991","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1086\/314879","article-title":"Cytomegalovirus (CMV)-Specific T Cell Immunity After Renal Transplantation Mediates Protection From CMV Disease by Limiting the Systemic Virus Load","volume":"180","author":"Reusser","year":"1999","journal-title":"J\u00a0Infect Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2502","article-title":"Primary Immune Responses to Human CMV: A Critical Role for IFN-Gamma-Producing CD4+ T Cells in Protection Against CMV Disease","volume":"101","author":"Gamadia","year":"2003","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.4.2625","article-title":"Persistent Cytomegalovirus-Specific Memory Responses in the Lung Allograft and Blood Following Primary Infection in Lung Transplant Recipients","volume":"176","author":"Shlobin","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1086\/508997","article-title":"Protective Immunity to Cytomegalovirus (CMV) Retinitis in AIDS Is Associated With CMV-Specific T Cells That Express Interferon- Gamma and Interleukin-2 and Have a CD8+ Cell Early Maturational Phenotype","volume":"194","author":"Sinclair","year":"2006","journal-title":"J Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1352912","article-title":"Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of Cellular Immunity Against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones From the Donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.55.2.264-273.1985","article-title":"Interstitial Murine Cytomegalovirus Pneumonia After Irradiation: Characterization of Cells That Limit Viral Replication During Established Infection of the Lungs","volume":"55","author":"Reddehase","year":"1985","journal-title":"J Virol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-008-0093-2","article-title":"CD8 T-Cell-Based Immunotherapy of Cytomegalovirus Infection: \u201cProof of Concept\u201d Provided by the Murine Model","volume":"197","author":"Holtappels","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.1.546","article-title":"Differential CMV-Specific CD8+ Effector T Cell Responses in the Lung Allograft Predominate Over the Blood During Human Primary Infection","volume":"181","author":"Pipeling","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12256","article-title":"Pretransplant Immediately Early-1-Specific T Cell Responses Provide Protection for CMV Infection After Kidney Transplantation","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042384","article-title":"Protection From Cytomegalovirus After Transplantation Is Correlated With Immediate Early 1-Specific CD8 T Cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005895","article-title":"The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy Against Mouse Cytomegalovirus Infection","volume":"12","author":"Panagioti","year":"2016","journal-title":"PloS Pathog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.9.5400-5413.2005","article-title":"Highly Protective In Vivo Function of Cytomegalovirus IE1 Epitope-Specific Memory CD8 T Cells Purified by T-Cell Receptor-Based Cell Sorting","volume":"79","author":"Pahl-Seibert","year":"2005","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00268-17","article-title":"Progress Toward Development of a Vaccine Against Congenital Cytomegalovirus Infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin\u00a0Vaccine Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine Prevention of Maternal Cytomegalovirus Infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and Efficacy of a Cytomegalovirus Glycoprotein B (Gb) Vaccine in Adolescent Girls: A Randomized Clinical Trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb3611","article-title":"Antibody Binding to Native Cytomegalovirus Glycoprotein B Predicts Efficacy of the Gb\/MF59 Vaccine in Humans","volume":"12","author":"Jenks","year":"2020","journal-title":"Sci Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0653-5","article-title":"Cytomegalovirus Vaccines: Current Status and Future Prospects","volume":"76","author":"Anderholm","year":"2016","journal-title":"Drugs"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-7570-z","article-title":"Entry of Herpesviruses Into Mammalian Cells","volume":"65","author":"Heldwein","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90200-9","article-title":"Human Cytomegalovirus Penetrates Host Cells by pH-Independent Fusion at the Cell Surface","volume":"191","author":"Compton","year":"1992","journal-title":"Virology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2019.1652539","article-title":"A Poly-Neoantigen DNA Vaccine Synergizes With PD-1 Blockade to Induce T Cell-Mediated Tumor Control","volume":"8","author":"Tondini","year":"2019","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0706296105","article-title":"Antigen Kinetics Determines Immune Reactivity","volume":"105","author":"Johansen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000339","article-title":"Murine Cytomegalovirus Infection via the Intranasal Route Offers a Robust Model of Immunity Upon Mucosal CMV Infection","volume":"97","author":"Oduro","year":"2015","journal-title":"J\u00a0Gen Virol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"362ra145","DOI":"10.1126\/scitranslmed.aaf9387","article-title":"A Replication-Defective Human Cytomegalovirus Vaccine for Prevention of Congenital Infection","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz141","article-title":"Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects","volume":"220","author":"Adler","year":"2019","journal-title":"J Infect Dis"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.8.4600","article-title":"Insufficient APC Capacities of Dendritic Cells in Gene Gun-Mediated DNA Vaccination","volume":"176","author":"Lauterbach","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.smim.2007.12.001","article-title":"Follicular Dendritic Cell Networks of Primary Follicles and Germinal Centers: Phenotype and Function","volume":"20","author":"Allen","year":"2008","journal-title":"Semin Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir138","article-title":"Glycoprotein B Vaccine Is Capable of Boosting Both Antibody and CD4 T-Cell Responses to Cytomegalovirus in Chronically Infected Women","volume":"203","author":"Sabbaj","year":"2011","journal-title":"J Infect Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.029413-0","article-title":"Recombinant Glycoprotein B Vaccine Formulation With Toll-Like Receptor 9 Agonist and Immune-Stimulating Complex Induces Specific Immunity Against Multiple Strains of Cytomegalovirus","volume":"92","author":"Dasari","year":"2011","journal-title":"J Gen Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00144","article-title":"Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses Against Mouse Cytomegalovirus Infection","volume":"8","author":"Panagioti","year":"2017","journal-title":"Front Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1099\/vir.0.025742-0","article-title":"Delineating the Role of CD4+ T Cells in the Activation of CMV-Specific Immune Responses Following Immunization With Ad-Gbcmvpoly Vaccine: Implications for Vaccination of Immunocompromised Individuals","volume":"91","author":"Zhong","year":"2010","journal-title":"J Gen Virol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1126\/science.273.5273.352","article-title":"Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization","volume":"273","author":"Sato","year":"1996","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501836","article-title":"A cGAS-Independent STING\/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines","volume":"196","author":"Suschak","year":"2016","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.6.3760","article-title":"Genome-Wide Analysis Reveals a Highly Diverse CD8 T Cell Response to Murine Cytomegalovirus","volume":"176","author":"Munks","year":"2006","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.11.7569-7579.1996","article-title":"The Human Cytotoxic T-Lymphocyte (CTL) Response to Cytomegalovirus Is Dominated by Structural Protein Pp65: Frequency, Specificity, and T-Cell Receptor Usage of Pp65-Specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.056","article-title":"Novel Trimeric Human Cytomegalovirus Glycoprotein B Elicits a High-Titer Neutralizing Antibody Response","volume":"36","author":"Cui","year":"2018","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316517110","article-title":"Pentameric Complex of Viral Glycoprotein H Is the Primary Target for Potent Neutralization by a Human Cytomegalovirus Vaccine","volume":"110","author":"Freed","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.05.004","article-title":"Human Cytomegalovirus Gh\/Gl\/UL128\/UL130\/UL131A Complex Elicits Potently Neutralizing Antibodies in Mice","volume":"32","author":"Wen","year":"2014","journal-title":"Vaccine"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01809-09","article-title":"Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the Gh\/Gl\/UL128-131A Complex","volume":"84","author":"Macagno","year":"2010","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00121-16","article-title":"Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer Gh\/Gl\/Pul128l and Trimer Gh\/Gl\/gO as Well as Antibodies Elicited During Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation","volume":"90","author":"Gerna","year":"2016","journal-title":"J Virol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003231","article-title":"Differential B7-CD28 Costimulatory Requirements for Stable and Inflationary Mouse Cytomegalovirus-Specific Memory CD8 T Cell Populations","volume":"186","author":"Arens","year":"2011","journal-title":"J\u00a0Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.680559\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T11:08:55Z","timestamp":1643281735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.680559\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":69,"alternative-id":["10.3389\/fimmu.2022.680559"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.680559","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]},"article-number":"680559"}}